ACORDA THERAPEUTICS INC (ACOR) 34.84 -$0.45 (-1.28%) 10:24AM (15 mins delay)

ACORDA THERAPEUTICS INC (ACOR) News

Acorda Therapeutics to Present at the Cowen and Company 30th Annual Health Care Conference <META HTTP-EQUIV="CACHE-CONTROL" CONTENT="NO-CACHE"> <table width='100%' cellspacing=0 cellpadding=0 border=0/><tr><td> <style> <%=newsItem.getTextStyle(contextData) %> a.buttonlinks:link, a.buttonlinks:visited { display:block; border:1px solid...	03/02/2010
Acorda Therapeutics Announces Availability of AMPYRA(TM) (dalfampridine)	03/01/2010
Acorda Therapeutics to Participate in Panel at the RBC Capital Markets Healthcare Conference	02/25/2010
Wall Street Breakfast: Must-Know News	02/23/2010
Acorda Therapeutics Reports Fourth Quarter and Full Year 2009 Financial Results	02/23/2010
Acorda Therapeutics Announces Adrian L. Rabinowicz Joins as Senior Vice President of Medical Affairs	02/22/2010
Report of unscheduled material events or corporate changes - Form 8-K	02/22/2010	SEC Filings
Acorda Therapeutics to Host Conference Call to Report Fourth Quarter and Full Year 2009 Financial Results on February 23, 2010	02/17/2010
An amendment to the SC 13G filing - Form SC 13G/A	02/16/2010	SEC Filings
Cramer's Lightning Round - Dole Is in the Hole (2/9/10)	02/10/2010
Wild Weekly Wrap-Up: Everyone Just Relax	02/08/2010
Acorda Therapeutics to Present at the 12th Annual BIO CEO & Investor Conference	02/03/2010
Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA(TM) (dalfampridine)	02/03/2010
Report of unscheduled material events or corporate changes - Form 8-K	02/03/2010	SEC Filings
Initial statement of beneficial ownership of securities - Form 3	02/02/2010	SEC Filings
Securities offered to employees pursuant to employee benefit plans - Form S-8	02/01/2010	SEC Filings
A statement of beneficial ownership of common stock by certain persons - Form SC 13G	01/29/2010	SEC Filings
Report of unscheduled material events or corporate changes - Form 8-K	01/29/2010	SEC Filings
Acorda Should Reap Rewards for MS Drug Ampyra	01/28/2010
Acorda's MS Drug May Not Be the Windfall Investors Expect	01/27/2010
Tightening Tuesday: Global Edition	01/26/2010
Acorda MS Drug Gets FDA Clearance	01/26/2010
Acorda: After FDA Approval, What's Next for Ampyra?	01/25/2010
Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development	01/25/2010
Report of unscheduled material events or corporate changes - Form 8-K	01/25/2010	SEC Filings

Displaying 1 - 25 of 262